TABLE 9.
In vitro susceptibility to four antifungal drugsa
| Fungus | MIC range (μg/ml) (no. of isolates tested) of:
|
|||
|---|---|---|---|---|
| Voriconazole | Amphotericin B | Fluconazole | Itraconazole | |
| Blastomyces dermatitidis | s≤0.03–1 (37) | ≤0.03–1 (28) | 1–64 (30) | ≤0.03–1 (33) |
| Coccidioides immitis | ≤0.03–0.125 (38) | 0.125–1 (27) | 2–64 (29) | 0.125–2 (27) |
| Histoplasma capsulatum | ≤0.03–1 (39) | ≤0.03–2 (31) | ≤0.125–64 (29) | ≤0.03–8 (31) |
| Paracoccidioides brasiliensis | ≤0.03–2 (19) | 0.125–4 (14) | ≤0.125–64 (14) | ≤0.03–1 (14) |
| Penicillium marneffei | ≤0.03 (27) | ≤0.03–8 (25) | 1–8 (25) | ≤0.03–2 (25) |
| Pseudallescheria boydii | 0.06–1 (23) | 2–≥16 (23) | 4–64 (23) | 1–4 (23) |
| Sporothrix schenckii | 0.50–6 (32) | 0.025–2 (23) | 32–≥128 (23) | 0.25–4 (26) |
| Trichosporon beigelii group | ≤0.03–1 (24) | 0.125–≥16 (24) | 0.5–≥128 (24) | 0.125–2 (24) |
Adapted from reference 158.